Association between Drug Therapy and Risk of Incident Frailty: A Systematic Review
- Author:
Saran THANAPLUETIWONG
1
;
Tanchanok CHATTARIS
;
Sandra Miao SHI
;
Chan Mi PARK
;
Stephanie Denise M. SISON
;
Dae Hyun KIM
Author Information
- Publication Type:Review Article
- From: Annals of Geriatric Medicine and Research 2024;28(3):247-256
- CountryRepublic of Korea
- Language:English
- Abstract: Medication is a potential factor influencing frailty. However, the relationship between pharmaceutical treatments and frailty remains unclear. Therefore, we conducted the present systematic review to summarize the association between drug therapy and the risk of incident frailty in older adults. We systematically searched the MEDLINE electronic database for articles indexed between January 1, 2000, and December 31, 2021, for randomized controlled trials (RCTs) and cohort studies reporting frailty changes associated with drug therapy. A total of six RCTs and 13 cohort studies involving 211,948 participants were identified, and their treatments were categorized into six medication classes: analgesics, cardiometabolic medication, chemotherapy, central nervous system (CNS)-active medication, hormonal therapy, and nutritional supplements. While the analysis revealed that only CNS-active medications were associated with an elevated risk of frailty, other medication classes also affected frailty; however, this is not conclusively attributable to a class-wide effect.
